Pfizer requests FDA approval for adolescent COVID-19 vaccine, provides update on clinical trial for under-5 age group

Dec 17, 2021 - 12:09 PM
A clinician delivers a flu vaccine into a female patient's right arm.

Pfizer yesterday said it has submitted a supplemental biologics license application for its COVID-19 vaccine, asking that the Food and Drug Administration expand approval to include individuals age 12 to 15. The supplemental application includes longer-term follow-up data from its ongoing phase 3 clinical trial for this age group, which continues to affirm its extremely high efficacy among these patients.

Pfizer also provided an update on its clinical study of the vaccine’s efficacy and safety among children between 6 months and 5 years old. Each dose for that group is three micrograms. As part of the update, Pfizer revealed that it is evaluating the addition of a third dose for the younger group, administered two months after the completion of an initial two-dose regimen. Pfizer also plans to evaluate the 5-12 age group’s response to a third dose of the 10-micogram formulation currently administered to those children.
 

Related News Articles

Headline
FDA seeks feedback on measuring AI-enabled medical device performance
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
Olympus recalls endoscope needles
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
ACIP recommends patients consult their provider for COVID-19 vaccine
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
FDA issues serious recall for electric wheelchair joysticks
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
CDC says COVID-19 cases growing or likely growing in 45 states 
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease…
Headline
FDA announces recall of cefazolin by Sandoz for mislabeling
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…